SIRT1 silencing ameliorates malignancy of non-small cell lung cancer via activating FOXO1

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
• Understanding the molecular mechanisms driving NSCLC progression is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the role and underlying mechanisms of silent information regulator type-1 (SIRT1) in NSCLC.
• To determine if SIRT1 acts as a tumor suppressor or oncogene in NSCLC.

Main Methods:

• Quantitative real-time PCR and western blotting to assess SIRT1 expression in NSCLC cell lines.
• In vitro functional assays (proliferation, migration, invasion, apoptosis) and in vivo tumorigenicity studies.
• Pharmacological inhibition of the FOXO1 pathway to elucidate SIRT1's mechanism of action.

Main Results:

• SIRT1 expression was significantly upregulated in NSCLC cell lines.
• SIRT1 depletion suppressed NSCLC cell proliferation, migration, and invasion, while promoting apoptosis.
• In vivo studies demonstrated that SIRT1 silencing restricted NSCLC tumor growth.
• Inhibition of FOXO1 partially reversed the anti-oncogenic effects of SIRT1 deficiency.

Conclusions:

• SIRT1 plays a critical role in promoting NSCLC progression.
• SIRT1 exerts its anti-oncogenic effects in NSCLC through the activation of the FOXO1 pathway.
• Targeting SIRT1 may represent a potential therapeutic strategy for NSCLC.